Citation Impact

Citing Papers

The Retinal Pigment Epithelium in Visual Function
2005 Standout
The Ocular Hypertension Treatment Study
2002 Standout
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
Ocular Drug Delivery
2010 Standout
Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects
2009 Standout
Factors for Glaucoma Progression and the Effect of Treatment
2003 Standout
Reduction of Intraocular Pressure and Glaucoma Progression
2002 Standout
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age‐Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults
2016 Standout
Müller cells in the healthy and diseased retina
2006 Standout
The Quality of Medical Evidence and Medical Practice
2020
Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy
1997
Randomized Clinical Trials on Medical Treatment of Glaucoma
1993
Retinopathy induced in mice by targeted disruption of the rhodopsin gene
1997 StandoutNobel
Clinical Variation of Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy (APECED) in a Series of 68 Patients
1990 Standout
Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease
1989
Retinitis pigmentosa
1988
Fundus albipunctatus: A clinical study of the fundus lesions, the physiologic deficit, and the vitamin a metabolism
1977
Hepatic zonation of the catabolism of arginine and ornithine in the perfused rat liver
1998
Gyrate atrophy of the choroid and retina with hyperornithinemia. Deficient formation of guanidinoacetic acid from arginine.
1980
Ornithinemia, Hyperammonemia, and Homocitrullinuria
1974
Inhibition of arginine-glycine amidinotransferase by ornithine. A possible mechanism for the muscular and chorioretinal atrophies in gyrate atrophy of the choroid and retina with hyperornithinemia
1980
Gyrate Atrophy of the Choroid and Retina
1985
At least two mutant alleles of ornithine delta-aminotransferase cause gyrate atrophy of the choroid and retina in Finns.
1989
Prevention of Ornithine Cytotoxicity by Nonpolar Side Chain Amino Acids in Retinal Pigment Epithelial Cells
2003
Supplementary Creatine as a Treatment for Gyrate Atrophy of the Choroid and Retina
1981
Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences.
1992
Gyrate atrophy of the choroid and retina: deficiency of ornithine aminotransferase in transformed lymphocytes.
1977
Arginine metabolism: nitric oxide and beyond
1998 Standout
Creatine and Creatinine Metabolism
2000 Standout

Works of K Takki being referenced

A Double-Masked Study of Timolol and Pilocarpine Combined
1987
Timolol treatment of chronic open-angle glaucoma and ocular hypertension
1982
The Natural History of Gyrate Atrophy of the Choroid and Retina
1981
Expression defect of ornithine aminotransferase gene in gyrate atrophy.
1988
Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia.
1974
Gyrate atrophy of the choroid and retina with hyperornithinemia HOGA.
1976
Differential diagnosis between the primary total choroidal vascular atrophies.
1974
Systemic Manifestations of Gyrate Atrophy of the Choroid and Retina
1981
RAISED PLASMA-ORNITHINE AND GYRATE ATROPHY OF THE CHOROID AND RETINA
1973
Gyrate atrophy of the choroid and retina associated with hyperornithinaemia.
1974
Cataract in gyrate atrophy: clinical and morphologic studies.
1983
Gyrate Atrophy of the Choroid and Retina
1981
Rankless by CCL
2026